| Digestive And Liver Disease Specialists A Medical Group Inc | |
|
1771 W Romneya Dr Suite C Anaheim CA 92801 | |
| (714) 758-0403 | |
| (714) 917-0785 |
| Full Name | Digestive And Liver Disease Specialists A Medical Group Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1771 W Romneya Dr, Anaheim, California |
| Authorized Official Name and Position | Raja R Alapati (BILLING CLERK) |
| Authorized Official Contact | 7147580403 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Digestive And Liver Disease Specialists A Medical Group Inc 1771 W Romneya Dr Suite C Anaheim CA 92801 Ph: (714) 758-0403 | Digestive And Liver Disease Specialists A Medical Group Inc 1771 W Romneya Dr Suite C Anaheim CA 92801 Ph: (714) 758-0403 |
| NPI Number | 1760469209 |
|---|---|
| Provider Enumeration Date | 12/27/2005 |
| Last Update Date | 09/13/2013 |
| Medicare PECOS PAC ID | 8729987144 |
|---|---|
| Medicare Enrollment ID | O20040105000891 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760469209 | NPI | - | NPPES |
| GR0055870 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Ravindra Alapati |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1912989773 PECOS PAC ID: 1456250877 Enrollment ID: I20040526001069 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
| Provider Name | Syam P Gaddam |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1275510711 PECOS PAC ID: 0547169963 Enrollment ID: I20040720001636 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
| Provider Name | Gayatri Subedi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043356173 PECOS PAC ID: 6204931991 Enrollment ID: I20110620000650 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
| Provider Name | Tahmina S Haq |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1538332853 PECOS PAC ID: 1850565466 Enrollment ID: I20151104002393 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
| Provider Name | Amit Raina |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1316138142 PECOS PAC ID: 9436242807 Enrollment ID: I20220502001044 |
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
News Archive
New research revealed today by the National SAFE KIDS Campaign and Johnson & Johnson shows that 88 percent of children who drowned were under the supervision of another person, usually a family member. Supervision was defined as being in the care of another individual, not necessarily in their direct line of sight.
Baxter International Inc. today announced that the United States Food and Drug Administration granted approval of Baxter's FEIBA [Anti-Inhibitor Coagulant Complex], the first and only FDA-approved treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A or B who have developed inhibitors.
These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.
With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.
› Verified 1 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |